BeiGene to Present at the J.P. Morgan 41st Annual Healthcare Conference
January 04 2023 - 7:07AM
Business Wire
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global
biotechnology company today announced that the Company will
participate in the J.P. Morgan 41st Annual Healthcare Conference on
Monday, January 9, 2023 at 1:30 p.m. PT.
A live webcast can be accessed from the investors section of
BeiGene’s website at http://ir.beigene.com. An archived replay will
be available for 90 days following the event.
About BeiGene
BeiGene is a global biotechnology company that is developing and
commercializing innovative and affordable oncology medicines to
improve treatment outcomes and access for far more patients
worldwide. With a broad portfolio, we are expediting development of
our diverse pipeline of novel therapeutics through our internal
capabilities and collaborations. We are committed to radically
improving access to medicines for far more patients who need them.
Our growing global team of more than 9,000 colleagues spans five
continents, with administrative offices in Cambridge, U.S., &
Basel, Switzerland & Beijing, China. To learn more about
BeiGene, please visit www.beigene.com and follow us on Twitter at
@BeiGeneGlobal.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230104005542/en/
Investor: Kevin Mannix +1 240-410-0129 ir@beigene.com
Media: Kyle Blankenship +1 667- 351-5176
media@beigene.com
BeiGene (NASDAQ:BGNE)
Historical Stock Chart
From Jun 2024 to Jul 2024
BeiGene (NASDAQ:BGNE)
Historical Stock Chart
From Jul 2023 to Jul 2024
